Technical Analysis for TRSBF - 3Sbio Inc

Grade Last Price % Change Price Change
grade C 1.43 -1.38% -0.0200
TRSBF closed down 1.38 percent on Monday, December 2, 2019, on 67 percent of normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical TRSBF trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Gapped Down Weakness 0.00%
New 52 Week Closing Low Bearish -1.38%
Narrow Range Bar Range Contraction -1.38%
New 52 Week Low Weakness -1.38%
Gapped Down Weakness -1.38%

Older signals for TRSBF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

3SBio Inc. develops, manufactures, markets, and sells biopharmaceuticals. The company's primary products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; Yisaipu, a tumour necrosis factor for treating rheumatoid arthritis, ankylosing spondylitis, and psoriasis; EPIAO, a recombinant human erythropoietin for the treatment of anemia associated with chronic kidney disease (CKD), chemotherapy-induced anemia, and reduction of allogeneic blood transfusion in surgery patients; SEPO, a recombinant human erythropoietin for anemia associated with CKD and chemotherapy; Byetta/Bydureon, an exenatide injection to improve glycemic control in adults with type-2 diabetes mellitus; and Qiming Keli for retinopathy caused by type-2 diabetes. It also offers Ruisiyi to treat advanced breast cancer; Wanwei for treating vomiting caused by cytotoxic chemotherapy; and Intefen to treat lymphatic or hematopoietic malignancies and viral infections. In addition, the company provides Inleusin for renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer, and tuberculosis; Etanercept for moderate to severe rheumatoid arthritis and plaque psoriasis, and active ankylosing spondylitis; and Sparin for prophylaxis and vein thrombosis, and to prevent clotting during hemodialysis. Further, it offers Mandi for male-pattern alopecia and alopecia areata; Aiyishu for iron-deficiency anemia; Disu to prevent and treat chronic bronchitis, colds, and asthma; Jiannipai to prevent acute rejection after renal transplantation; and Humulin for diabetes, as well as contract development and manufacturing, trading, project management and consultation, and technology services. The company markets its products through in-house sales and marketing team, as well as distributors and third-party promoters. The company has a collaboration agreement with Samsung Bioepis Co., Ltd. 3SBio Inc. was incorporated in 2006 and is headquartered in Shenyang, the People's Republic of China.
Medicine Manufacturing Medical Specialties RTT Cancer Biopharmaceutical Clinical Medicine Project Management Diabetes Surgery Chemotherapy Technology Services Arthritis Psoriasis Asthma Rheumatoid Arthritis Melanoma Transplantation Chronic Kidney Disease Hemodialysis Biopharmaceuticals Anemia Vomiting Spondylitis Renal Cell Carcinoma Plaque Psoriasis Tuberculosis Alopecia Areata Chemotherapy Induced Anemia Erythropoietin Thrombocytopenia Viral Infections Chronic Bronchitis

Is TRSBF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 1.55
52 Week Low 1.43
Average Volume 150
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 0.0000
Average True Range 0.0000
ADX 0.0
+DI 0.0000
-DI 0.0000
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.0000
MACD Signal Line 0.0000
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.4300
Resistance 3 (R3) 1.4300 1.4300 1.4300
Resistance 2 (R2) 1.4300 1.4300 1.4300 1.4300
Resistance 1 (R1) 1.4300 1.4300 1.4300 1.4300 1.4300
Pivot Point 1.4300 1.4300 1.4300 1.4300 1.4300
Support 1 (S1) 1.4300 1.4300 1.4300 1.4300 1.4300
Support 2 (S2) 1.4300 1.4300 1.4300 1.4300
Support 3 (S3) 1.4300 1.4300 1.4300
Support 4 (S4) 1.4300